Skip to NavigationSkip to content

News

In a deal that sounds more like something to come out of a science-fiction novel, Applied DNA Sciences has agreed a five-year deal with an unnamed...
The FDA has announced that it will require medication including codeine and tramadol, two high-strength painkillers, to have its strongest warning on...
From Novartis and Allergan's new partnership to tackle NASH to some shocking trial results from AbbVie and Circassia, check out the top ten most...
GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the first to introduce a competitor, after...
Deal-making in the global pharmaceuticals sector is booming, with no signs of slowing down.
AbbVie have released that two Phase 3 trials of its experimental cancer drug, veliparib, missed both of their primary endpoints.
A team of scientists have identified methods to prevent neurodegeneration in mice, leading to new hopes in the treatment of diseases such as...
Alpine Immune Sciences has agreed a deal to merge with Nivalis Therapeutics, in an all-stock deal. The deal will create a biotech with cash $90...
An investigational drug from ImmunoGen could prove effective in treating platinum-resistant ovarian cancer, an area of significant unmet need with...
‘World Hemophilia Day’ occurred on 17 April and the day was marked by the release of data from two companies involved in treating the condition.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches